240 related articles for article (PubMed ID: 26179481)
1. The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.
Rida PC; LiVecche D; Ogden A; Zhou J; Aneja R
Med Res Rev; 2015 Sep; 35(5):1072-96. PubMed ID: 26179481
[TBL] [Abstract][Full Text] [Related]
2. Noscapine comes of age.
Chen X; Dang TT; Facchini PJ
Phytochemistry; 2015 Mar; 111():7-13. PubMed ID: 25583437
[TBL] [Abstract][Full Text] [Related]
3. Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents.
DeBono A; Capuano B; Scammells PJ
J Med Chem; 2015 Aug; 58(15):5699-727. PubMed ID: 25811651
[TBL] [Abstract][Full Text] [Related]
4. Biological and pharmacological activities of noscapine: Focusing on its receptors and mechanisms.
Nourbakhsh F; Askari VR
Biofactors; 2021 Nov; 47(6):975-991. PubMed ID: 34534373
[TBL] [Abstract][Full Text] [Related]
5. Determination of noscapine's localization and interaction with the tubulin-α/β heterodimer.
Alisaraie L; Tuszynski JA
Chem Biol Drug Des; 2011 Oct; 78(4):535-46. PubMed ID: 21781284
[TBL] [Abstract][Full Text] [Related]
6. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics.
Lopus M; Naik PK
Pharmacol Rep; 2015 Feb; 67(1):56-62. PubMed ID: 25560576
[TBL] [Abstract][Full Text] [Related]
7. A Papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine.
Winzer T; Gazda V; He Z; Kaminski F; Kern M; Larson TR; Li Y; Meade F; Teodor R; Vaistij FE; Walker C; Bowser TA; Graham IA
Science; 2012 Jun; 336(6089):1704-8. PubMed ID: 22653730
[TBL] [Abstract][Full Text] [Related]
8. Noscapine and its Analogs as Chemotherapeutic Agent: Current updates.
Tomar V; Kukreti S; Prakash S; Madan J; Chandra R
Curr Top Med Chem; 2017; 17(2):174-188. PubMed ID: 27237331
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
[TBL] [Abstract][Full Text] [Related]
10. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
[TBL] [Abstract][Full Text] [Related]
11. Engineering biosynthesis of the anticancer alkaloid noscapine in yeast.
Li Y; Smolke CD
Nat Commun; 2016 Jul; 7():12137. PubMed ID: 27378283
[TBL] [Abstract][Full Text] [Related]
12. The anti-cancer activity of noscapine: a review.
Mahmoudian M; Rahimi-Moghaddam P
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):92-7. PubMed ID: 19149691
[TBL] [Abstract][Full Text] [Related]
13. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
Santoshi S; Naik PK; Joshi HC
J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
[TBL] [Abstract][Full Text] [Related]
14. Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.
Pannu V; Rida PC; Celik B; Turaga RC; Ogden A; Cantuaria G; Gopalakrishnan J; Aneja R
Cell Death Dis; 2014 Nov; 5(11):e1538. PubMed ID: 25412316
[TBL] [Abstract][Full Text] [Related]
15. Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent, noscapine in cancer cells.
Chandra R; Madan J; Singh P; Chandra A; Kumar P; Tomar V; Dass SK
Curr Drug Metab; 2012 Dec; 13(10):1476-83. PubMed ID: 22571485
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of N-substituted noscapine analogues.
DeBono AJ; Xie JH; Ventura S; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2012 Dec; 7(12):2122-33. PubMed ID: 23055449
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library.
Nemati F; Bischoff-Kont I; Salehi P; Nejad-Ebrahimi S; Mohebbi M; Bararjanian M; Hadian N; Hassanpour Z; Jung Y; Schaerlaekens S; Lucena-Agell D; Oliva MA; Fürst R; Nasiri HR
Bioorg Chem; 2021 Oct; 115():105135. PubMed ID: 34303039
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
19. Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells.
Cheriyamundath S; Mahaddalkar T; Kantevari S; Lopus M
Biomed Pharmacother; 2017 Feb; 86():74-80. PubMed ID: 27939522
[TBL] [Abstract][Full Text] [Related]
20. Recent patents reveal microtubules as persistent promising target for novel drug development for cancers.
Bughani U; Li S; Joshi HC
Recent Pat Antiinfect Drug Discov; 2009 Nov; 4(3):164-82. PubMed ID: 19673697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
